MIGUEL CERVANTES-LOPEZ: Open Payments
NPI 1689829327 · UPLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,601 in 108 payments from 11 companies in 2025. Trend: 2023 $403 · 2024 $1,175 · 2025 $2,601
Food & beverage: $2,601
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 43 | $1,041 |
| Ardelyx, Inc. | 17 | $392 |
| Janssen Biotech, Inc. | 9 | $349 |
| ABBVIE INC. | 11 | $277 |
| Ipsen Biopharmaceuticals, Inc | 3 | $182 |
| Phathom Pharmaceuticals, Inc. | 14 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $102 |
| GENZYME CORPORATION | 3 | $82 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| VIVUS LLC | 1 | $20 |
Products named: REZDIFFRA, IBSRELA, TREMFYA, IQIRVO, VOQUEZNA, DUPIXENT, CREON, SKYRIZI.
Industry payments across CA — which companies pay providers there.
